More on BCYC
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $4.04 |
|
|||
| Open | $4.15 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $4.19 | ||||
| Day Low | $3.98 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 317,933 | ||||
- Bicycle Therapeutics (BCYC) Reiterated at Market Outperform by Citizens
- Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting
- Hippocratic AI Expands Life Sciences Leadership Team as Pharma and Medtech Demand for Voice AI Agents Accelerates
- TRIANA Biomedicines appoints Mohan Bala as chief operating officer
- TRIANA Biomedicines Announces the Appointment of Mohan Bala as Chief Operating Officer and Attracts Leading Experts to its Scientific Advisory Board
- William Blair Accelerates Investment in Biotech Equity Research and Equities Platform
- Bicycle Therapeutics (BCYC) PT Lowered to $7 at Truist Securities
- Bicycle Therapeutics (BCYC) PT Lowered to $12 at Jefferies
- Bicycle Therapeutics plc (BCYC) Misses Q1 EPS by 20c
- Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
Entities mentioned with BCYC
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- 13G | View Related Stories »
- FDA | View Related Stories »
- Jefferies & Co | View Related Stories »
- Twitter | View Related Stories »
- Show More...
